J B Chemicals & Pharmaceuticals has allotted 2,500 equity shares under ESOS on 06 December 2025. Consequently, the issued, subscribed and paid-up capital has increased from 15,66,48,456 equity shares of Re. 1 each to 15,66,50,956 equity shares of Re. 1 each. Powered by Capital Market - Live News

Net profit of J B Chemicals & Pharmaceuticals rose 19.05% to Rs 207.82 crore in the quarter ended September 2025 as against Rs 174.57 crore during the previous quarter ended September 2024. Sales rose 8.42% to Rs 1084.90 crore in the quarter ended September 2025 as against Rs 1000.62 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales1084.901000.62 8 OPM %28.5427.04 - PBDT323.59278.41 16 PBT279.15236.53 18 NP207.82174.57 19 Powered by Capital Market - Live News

J B Chemicals & Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 11 November 2025.Powered by Capital Market - Live News

J B Chemicals & Pharmaceuticals has allotted 114,999 equity shares under ESOS on 14 August 2025. Consequently, the issued, subscribed and paid up capital has increased from 15,63,41,004 equity shares of Re. 1 each to 15,64,56,003 equity shares of Re. 1 each. Powered by Capital Market - Live News

J B Chemicals & Pharmaceuticals has allotted 23,003 equity shares under ESOS on 09 August 2025. Consequently, the issued, subscribed and paid up capital has increased from 15,63,18,001 equity shares of Re. 1 each to 15,63,41,004 equity shares of Re. 1 each. Powered by Capital Market - Live News